Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Edward Kislauskis"'
Autor:
Tim Wu, Roger J. Laham, Jianmin Xiao, Edward Kislauskis, Yuying Bi, Jiahao Chen, Tong Liao, Shuling Xie, Yangbo Xi, Yuanchun Zhang
Publikováno v:
Catheterization and Cardiovascular Interventions. 96
Objectives The aim of this study was to evaluate the long-term clinical safety and efficacy of drug-coated balloon (DCB) in the treatment of in-stent restenosis (ISR). Background There is a long-term safety issue in peripheral arterial disease patien
Autor:
Xiaoxin Zheng, Zhiyuan Lan, Yongnan Lyu, Yiyu He, Jianmin Xiao, Weiwang Gu, Qingru Xu, Edward Kislauskis, Stephen McCarthy, Roger Laham, Michael P. Robich, Tim Wu, Xuejun Jiang
Publikováno v:
Science of Advanced Materials. 8:1010-1019
Autor:
Tim Wu, Zhiyuan Lan, Qiang Hu, Jun Li, Gaoke Feng, Roger J. Laham, Jianmin Xiao, Edward Kislauskis, Kan Wu, Xiaoxin Zheng, Zhao Lu, Xuejun Jiang, Stephen P. McCarthy, Yuying Bi
Publikováno v:
Journal of Biomedical Nanotechnology. 12:743-752
Our previous studies have confirmed the superior biocompatibility of the poly-L-lactic acid/amorphous calcium phosphate (PLLA/ACP) scaffolds (PowerScaffold) compared to PLLA scaffolds and their similar 6-month radial strength compared with TAXUS sten
Autor:
Yongnan Lyu, Stephen P. McCarthy, Zhiyuan Lan, Shizu Tagusari, Yujue Wang, Xuejun Jiang, Roger J. Laham, Gaoke Feng, Frank W. Sellke, Xiaoxin Zheng, Michael P. Robich, Edward Kislauskis, Tim Wu, Wei Wang Gu, Yipei Zhang
Publikováno v:
Journal of Biomedical Nanotechnology. 10:900-910
Biodegradable polymers used as vascular stent coatings and stent platforms encounter a major challenge: biocompatibility in vivo, which plays an important role in in-stent restenosis (ISR). Co-formulating amorphous calcium phosphate (ACP) into poly(l
Autor:
Jiuhao Chen, Roger J. Laham, Tingfei Xi, Tianshi Liao, Jianmin Xiao, Qun Wang, Edward Kislauskis, Zhimin Wang, Tim Wu, Gaoke Feng, Jinxi Xia, Stephen P. McCarthy, Guanyang Kang, Zhicheng Huo, Zhiyuan Lan, Xuejun Jiang
Publikováno v:
Journal of biomedical nanotechnology. 11(10)
Rationale We reported previously, in porcine coronary arteries, that the novel biodegradable PowerStent Absorb paclitaxel-eluting stent had improved and sustained structural strength and functional performance at one month post-implantation. Objectiv